Your browser doesn't support javascript.
loading
Increased blood-brain barrier hyperpermeability coincides with mast cell activation early under cuprizone administration.
Shelestak, John; Singhal, Naveen; Frankle, Lana; Tomor, Riely; Sternbach, Sarah; McDonough, Jennifer; Freeman, Ernest; Clements, Robert.
Afiliação
  • Shelestak J; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • Singhal N; Department of Biochemistry, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Frankle L; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • Tomor R; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • Sternbach S; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • McDonough J; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • Freeman E; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
  • Clements R; Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Kent, Ohio, United States of America.
PLoS One ; 15(6): e0234001, 2020.
Article em En | MEDLINE | ID: mdl-32511268
ABSTRACT
The cuprizone induced animal model of demyelination is characterized by demyelination in many regions of the brain with high levels of demyelination in the corpus callosum as well as changes in neuronal function by 4-6 weeks of exposure. The model is used as a tool to study demyelination and subsequent degeneration as well as therapeutic interventions on these effects. Historically, the cuprizone model has been shown to contain no alterations to blood-brain barrier integrity, a key feature in many diseases that affect the central nervous system. Cuprizone is generally administered for 4-6 weeks to obtain maximal demyelination and degeneration. However, emerging evidence has shown that the effects of cuprizone on the brain may occur earlier than measurable gross demyelination. This study sought to investigate changes to blood-brain barrier permeability early in cuprizone administration. Results showed an increase in blood-brain barrier permeability and changes in tight junction protein expression as early as 3 days after beginning cuprizone treatment. These changes preceded glial morphological activation and demyelination known to occur during cuprizone administration. Increases in mast cell presence and activity were measured alongside the increased permeability implicating mast cells as a potential source for the blood-brain barrier disruption. These results provide further evidence of blood-brain barrier alterations in the cuprizone model and a target of therapeutic intervention in the prevention of cuprizone-induced pathology. Understanding how mast cells become activated under cuprizone and if they contribute to blood-brain barrier alterations may give further insight into how and when the blood-brain barrier is affected in CNS diseases. In summary, cuprizone administration causes an increase in blood-brain barrier permeability and this permeability coincides with mast cell activation.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Permeabilidade Capilar / Barreira Hematoencefálica / Doenças Desmielinizantes / Cuprizona / Mastócitos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Permeabilidade Capilar / Barreira Hematoencefálica / Doenças Desmielinizantes / Cuprizona / Mastócitos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos